nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlodipine—CA1—esophageal cancer	0.424	0.573	CbGaD
Amlodipine—CYP2A6—esophageal cancer	0.23	0.311	CbGaD
Amlodipine—ABCB1—esophageal cancer	0.0856	0.116	CbGaD
Amlodipine—CYP2C9—Capecitabine—esophageal cancer	0.0138	0.307	CbGbCtD
Amlodipine—CYP2B6—Cisplatin—esophageal cancer	0.0132	0.292	CbGbCtD
Amlodipine—CYP2C9—Cisplatin—esophageal cancer	0.00697	0.154	CbGbCtD
Amlodipine—ABCB1—Cisplatin—esophageal cancer	0.00677	0.15	CbGbCtD
Amlodipine—ABCB1—Methotrexate—esophageal cancer	0.00439	0.0973	CbGbCtD
Amlodipine—Coronary artery disease—Cisplatin—esophageal cancer	0.00177	0.0273	CcSEcCtD
Amlodipine—Bronchial hyperreactivity—Methotrexate—esophageal cancer	0.00147	0.0227	CcSEcCtD
Amlodipine—Chronic obstructive pulmonary disease—Methotrexate—esophageal cancer	0.00134	0.0208	CcSEcCtD
Amlodipine—CACNA2D3—lung—esophageal cancer	0.0011	0.0613	CbGeAlD
Amlodipine—CACNA1B—lung—esophageal cancer	0.00103	0.0575	CbGeAlD
Amlodipine—SMPD1—digestive system—esophageal cancer	0.000993	0.0554	CbGeAlD
Amlodipine—SMPD1—lung—esophageal cancer	0.00083	0.0463	CbGeAlD
Amlodipine—CACNA2D3—lymph node—esophageal cancer	0.000751	0.0419	CbGeAlD
Amlodipine—Pain—Carboplatin—esophageal cancer	0.000726	0.0112	CcSEcCtD
Amlodipine—CACNA1B—lymph node—esophageal cancer	0.000705	0.0393	CbGeAlD
Amlodipine—CACNA1C—smooth muscle tissue—esophageal cancer	0.000696	0.0389	CbGeAlD
Amlodipine—CACNB2—digestive system—esophageal cancer	0.000682	0.038	CbGeAlD
Amlodipine—Rash erythematous—Capecitabine—esophageal cancer	0.000672	0.0104	CcSEcCtD
Amlodipine—Coagulopathy—Capecitabine—esophageal cancer	0.000661	0.0102	CcSEcCtD
Amlodipine—Nilvadipine—CYP2A6—esophageal cancer	0.000656	0.239	CrCbGaD
Amlodipine—Rigors—Capecitabine—esophageal cancer	0.00063	0.00976	CcSEcCtD
Amlodipine—Extrasystoles—Capecitabine—esophageal cancer	0.000611	0.00947	CcSEcCtD
Amlodipine—Polyuria—Cisplatin—esophageal cancer	0.000577	0.00893	CcSEcCtD
Amlodipine—Skin discolouration—Capecitabine—esophageal cancer	0.000569	0.00882	CcSEcCtD
Amlodipine—CACNB2—lung—esophageal cancer	0.000569	0.0318	CbGeAlD
Amlodipine—SMPD1—lymph node—esophageal cancer	0.000567	0.0317	CbGeAlD
Amlodipine—Cardiac failure congestive—Cisplatin—esophageal cancer	0.000558	0.00865	CcSEcCtD
Amlodipine—Nocturia—Capecitabine—esophageal cancer	0.000554	0.00859	CcSEcCtD
Amlodipine—CACNA1C—digestive system—esophageal cancer	0.00055	0.0307	CbGeAlD
Amlodipine—Amnesia—Cisplatin—esophageal cancer	0.000539	0.00835	CcSEcCtD
Amlodipine—CACNA2D1—lung—esophageal cancer	0.000535	0.0298	CbGeAlD
Amlodipine—Nifedipine—ABCC2—esophageal cancer	0.000511	0.186	CrCbGaD
Amlodipine—Nifedipine—CYP2A6—esophageal cancer	0.000505	0.184	CrCbGaD
Amlodipine—CACNA1D—lung—esophageal cancer	0.000498	0.0278	CbGeAlD
Amlodipine—CA1—digestive system—esophageal cancer	0.000486	0.0271	CbGeAlD
Amlodipine—Urine output increased—Capecitabine—esophageal cancer	0.000465	0.0072	CcSEcCtD
Amlodipine—Orthostatic hypotension—Cisplatin—esophageal cancer	0.000463	0.00717	CcSEcCtD
Amlodipine—CACNA1C—lung—esophageal cancer	0.000459	0.0256	CbGeAlD
Amlodipine—Breast disorder—Cisplatin—esophageal cancer	0.000458	0.00709	CcSEcCtD
Amlodipine—Cramp muscle—Cisplatin—esophageal cancer	0.000456	0.00706	CcSEcCtD
Amlodipine—Abnormal vision—Capecitabine—esophageal cancer	0.000449	0.00695	CcSEcCtD
Amlodipine—CYP2A6—lung—esophageal cancer	0.000446	0.0249	CbGeAlD
Amlodipine—Diabetes mellitus—Capecitabine—esophageal cancer	0.000429	0.00665	CcSEcCtD
Amlodipine—Pancreatitis—Cisplatin—esophageal cancer	0.000429	0.00665	CcSEcCtD
Amlodipine—Sweating increased—Cisplatin—esophageal cancer	0.000426	0.00661	CcSEcCtD
Amlodipine—Polyuria—Capecitabine—esophageal cancer	0.000425	0.00659	CcSEcCtD
Amlodipine—Skin discolouration—Methotrexate—esophageal cancer	0.000424	0.00657	CcSEcCtD
Amlodipine—Vascular purpura—Capecitabine—esophageal cancer	0.000417	0.00646	CcSEcCtD
Amlodipine—Eye pain—Capecitabine—esophageal cancer	0.000414	0.00641	CcSEcCtD
Amlodipine—CA1—lung—esophageal cancer	0.000406	0.0226	CbGeAlD
Amlodipine—Hot flush—Capecitabine—esophageal cancer	0.000399	0.00618	CcSEcCtD
Amlodipine—Amnesia—Capecitabine—esophageal cancer	0.000397	0.00616	CcSEcCtD
Amlodipine—Increased appetite—Capecitabine—esophageal cancer	0.000397	0.00616	CcSEcCtD
Amlodipine—Menopausal symptoms—Capecitabine—esophageal cancer	0.000396	0.00613	CcSEcCtD
Amlodipine—Atrial fibrillation—Capecitabine—esophageal cancer	0.000394	0.0061	CcSEcCtD
Amlodipine—Thirst—Capecitabine—esophageal cancer	0.000392	0.00608	CcSEcCtD
Amlodipine—Vasculitis—Methotrexate—esophageal cancer	0.000392	0.00608	CcSEcCtD
Amlodipine—CACNB2—lymph node—esophageal cancer	0.000389	0.0217	CbGeAlD
Amlodipine—Purpura—Capecitabine—esophageal cancer	0.000387	0.006	CcSEcCtD
Amlodipine—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000383	0.00593	CcSEcCtD
Amlodipine—Conjunctivitis—Cisplatin—esophageal cancer	0.000379	0.00588	CcSEcCtD
Amlodipine—Osteoarthritis—Capecitabine—esophageal cancer	0.000373	0.00578	CcSEcCtD
Amlodipine—Diplopia—Capecitabine—esophageal cancer	0.000373	0.00578	CcSEcCtD
Amlodipine—Migraine—Capecitabine—esophageal cancer	0.000367	0.00569	CcSEcCtD
Amlodipine—CACNA2D1—lymph node—esophageal cancer	0.000366	0.0204	CbGeAlD
Amlodipine—CYP1A1—epithelium—esophageal cancer	0.000364	0.0203	CbGeAlD
Amlodipine—CYP1A1—bronchus—esophageal cancer	0.000358	0.02	CbGeAlD
Amlodipine—Bradycardia—Cisplatin—esophageal cancer	0.000357	0.00553	CcSEcCtD
Amlodipine—Mood swings—Capecitabine—esophageal cancer	0.000354	0.00548	CcSEcCtD
Amlodipine—Ataxia—Capecitabine—esophageal cancer	0.000351	0.00544	CcSEcCtD
Amlodipine—CYP2B6—bronchus—esophageal cancer	0.000348	0.0194	CbGeAlD
Amlodipine—Urine output increased—Methotrexate—esophageal cancer	0.000346	0.00536	CcSEcCtD
Amlodipine—Urinary tract disorder—Cisplatin—esophageal cancer	0.000346	0.00536	CcSEcCtD
Amlodipine—Connective tissue disorder—Cisplatin—esophageal cancer	0.000344	0.00533	CcSEcCtD
Amlodipine—Urethral disorder—Cisplatin—esophageal cancer	0.000343	0.00532	CcSEcCtD
Amlodipine—Gynaecomastia—Methotrexate—esophageal cancer	0.000343	0.00531	CcSEcCtD
Amlodipine—Dry skin—Capecitabine—esophageal cancer	0.000342	0.0053	CcSEcCtD
Amlodipine—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000341	0.00528	CcSEcCtD
Amlodipine—CACNA1D—lymph node—esophageal cancer	0.00034	0.019	CbGeAlD
Amlodipine—Visual impairment—Cisplatin—esophageal cancer	0.000338	0.00523	CcSEcCtD
Amlodipine—Breast disorder—Capecitabine—esophageal cancer	0.000337	0.00523	CcSEcCtD
Amlodipine—Gastritis—Capecitabine—esophageal cancer	0.00033	0.00512	CcSEcCtD
Amlodipine—Muscular weakness—Capecitabine—esophageal cancer	0.000329	0.0051	CcSEcCtD
Amlodipine—Eye disorder—Cisplatin—esophageal cancer	0.000327	0.00507	CcSEcCtD
Amlodipine—Tinnitus—Cisplatin—esophageal cancer	0.000327	0.00506	CcSEcCtD
Amlodipine—Cardiac disorder—Cisplatin—esophageal cancer	0.000325	0.00504	CcSEcCtD
Amlodipine—Flushing—Cisplatin—esophageal cancer	0.000325	0.00504	CcSEcCtD
Amlodipine—Dysphagia—Capecitabine—esophageal cancer	0.000323	0.005	CcSEcCtD
Amlodipine—CYP1A1—trachea—esophageal cancer	0.000322	0.0179	CbGeAlD
Amlodipine—Diabetes mellitus—Methotrexate—esophageal cancer	0.00032	0.00495	CcSEcCtD
Amlodipine—Polyuria—Methotrexate—esophageal cancer	0.000317	0.0049	CcSEcCtD
Amlodipine—Immune system disorder—Cisplatin—esophageal cancer	0.000316	0.0049	CcSEcCtD
Amlodipine—Mediastinal disorder—Cisplatin—esophageal cancer	0.000316	0.00489	CcSEcCtD
Amlodipine—Sweating increased—Capecitabine—esophageal cancer	0.000314	0.00487	CcSEcCtD
Amlodipine—CACNA1C—lymph node—esophageal cancer	0.000314	0.0175	CbGeAlD
Amlodipine—Arrhythmia—Cisplatin—esophageal cancer	0.000313	0.00485	CcSEcCtD
Amlodipine—Alopecia—Cisplatin—esophageal cancer	0.00031	0.0048	CcSEcCtD
Amlodipine—Malnutrition—Cisplatin—esophageal cancer	0.000305	0.00472	CcSEcCtD
Amlodipine—Dysuria—Capecitabine—esophageal cancer	0.000302	0.00467	CcSEcCtD
Amlodipine—Flatulence—Cisplatin—esophageal cancer	0.000301	0.00466	CcSEcCtD
Amlodipine—Weight increased—Capecitabine—esophageal cancer	0.000294	0.00455	CcSEcCtD
Amlodipine—Visual disturbance—Methotrexate—esophageal cancer	0.000293	0.00454	CcSEcCtD
Amlodipine—Muscle spasms—Cisplatin—esophageal cancer	0.000293	0.00454	CcSEcCtD
Amlodipine—Weight decreased—Capecitabine—esophageal cancer	0.000292	0.00452	CcSEcCtD
Amlodipine—Hyperglycaemia—Capecitabine—esophageal cancer	0.000291	0.00451	CcSEcCtD
Amlodipine—Tremor—Cisplatin—esophageal cancer	0.000286	0.00443	CcSEcCtD
Amlodipine—Ill-defined disorder—Cisplatin—esophageal cancer	0.000283	0.00438	CcSEcCtD
Amlodipine—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000282	0.00437	CcSEcCtD
Amlodipine—CYP1A2—digestive system—esophageal cancer	0.000281	0.0157	CbGeAlD
Amlodipine—Jaundice—Capecitabine—esophageal cancer	0.00028	0.00434	CcSEcCtD
Amlodipine—Conjunctivitis—Capecitabine—esophageal cancer	0.00028	0.00433	CcSEcCtD
Amlodipine—Osteoarthritis—Methotrexate—esophageal cancer	0.000278	0.00431	CcSEcCtD
Amlodipine—CA1—lymph node—esophageal cancer	0.000277	0.0155	CbGeAlD
Amlodipine—CYP1A1—digestive system—esophageal cancer	0.000277	0.0154	CbGeAlD
Amlodipine—Malaise—Cisplatin—esophageal cancer	0.000275	0.00426	CcSEcCtD
Amlodipine—Leukopenia—Cisplatin—esophageal cancer	0.000273	0.00423	CcSEcCtD
Amlodipine—Epistaxis—Capecitabine—esophageal cancer	0.000271	0.0042	CcSEcCtD
Amlodipine—CYP3A5—digestive system—esophageal cancer	0.000271	0.0151	CbGeAlD
Amlodipine—CYP2B6—digestive system—esophageal cancer	0.000269	0.015	CbGeAlD
Amlodipine—CYP2C9—digestive system—esophageal cancer	0.000266	0.0149	CbGeAlD
Amlodipine—Mood swings—Methotrexate—esophageal cancer	0.000263	0.00408	CcSEcCtD
Amlodipine—Bradycardia—Capecitabine—esophageal cancer	0.000263	0.00407	CcSEcCtD
Amlodipine—Ataxia—Methotrexate—esophageal cancer	0.000261	0.00405	CcSEcCtD
Amlodipine—Nisoldipine—ABCB1—esophageal cancer	0.000261	0.0951	CrCbGaD
Amlodipine—Myalgia—Cisplatin—esophageal cancer	0.00026	0.00402	CcSEcCtD
Amlodipine—Haemoglobin—Capecitabine—esophageal cancer	0.00026	0.00402	CcSEcCtD
Amlodipine—Rhinitis—Capecitabine—esophageal cancer	0.000259	0.00401	CcSEcCtD
Amlodipine—Anxiety—Cisplatin—esophageal cancer	0.000259	0.00401	CcSEcCtD
Amlodipine—Hepatitis—Capecitabine—esophageal cancer	0.000258	0.004	CcSEcCtD
Amlodipine—Haemorrhage—Capecitabine—esophageal cancer	0.000258	0.004	CcSEcCtD
Amlodipine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000258	0.00399	CcSEcCtD
Amlodipine—Hypoaesthesia—Capecitabine—esophageal cancer	0.000257	0.00398	CcSEcCtD
Amlodipine—Discomfort—Cisplatin—esophageal cancer	0.000257	0.00397	CcSEcCtD
Amlodipine—Urinary tract disorder—Capecitabine—esophageal cancer	0.000255	0.00395	CcSEcCtD
Amlodipine—Oedema peripheral—Capecitabine—esophageal cancer	0.000254	0.00394	CcSEcCtD
Amlodipine—Connective tissue disorder—Capecitabine—esophageal cancer	0.000254	0.00393	CcSEcCtD
Amlodipine—Urethral disorder—Capecitabine—esophageal cancer	0.000253	0.00392	CcSEcCtD
Amlodipine—Breast disorder—Methotrexate—esophageal cancer	0.000251	0.00389	CcSEcCtD
Amlodipine—Oedema—Cisplatin—esophageal cancer	0.000249	0.00386	CcSEcCtD
Amlodipine—Visual impairment—Capecitabine—esophageal cancer	0.000249	0.00386	CcSEcCtD
Amlodipine—Erythema multiforme—Capecitabine—esophageal cancer	0.000244	0.00378	CcSEcCtD
Amlodipine—Nervous system disorder—Cisplatin—esophageal cancer	0.000244	0.00378	CcSEcCtD
Amlodipine—Nitrendipine—ABCB1—esophageal cancer	0.000244	0.089	CrCbGaD
Amlodipine—Thrombocytopenia—Cisplatin—esophageal cancer	0.000244	0.00378	CcSEcCtD
Amlodipine—Tachycardia—Cisplatin—esophageal cancer	0.000243	0.00376	CcSEcCtD
Amlodipine—Skin disorder—Cisplatin—esophageal cancer	0.000242	0.00375	CcSEcCtD
Amlodipine—Eye disorder—Capecitabine—esophageal cancer	0.000241	0.00374	CcSEcCtD
Amlodipine—Tinnitus—Capecitabine—esophageal cancer	0.000241	0.00373	CcSEcCtD
Amlodipine—Hyperhidrosis—Cisplatin—esophageal cancer	0.000241	0.00373	CcSEcCtD
Amlodipine—Cardiac disorder—Capecitabine—esophageal cancer	0.00024	0.00371	CcSEcCtD
Amlodipine—Flushing—Capecitabine—esophageal cancer	0.00024	0.00371	CcSEcCtD
Amlodipine—Anorexia—Cisplatin—esophageal cancer	0.000237	0.00368	CcSEcCtD
Amlodipine—Pancreatitis—Methotrexate—esophageal cancer	0.000235	0.00365	CcSEcCtD
Amlodipine—Angiopathy—Capecitabine—esophageal cancer	0.000234	0.00363	CcSEcCtD
Amlodipine—CYP1A2—lung—esophageal cancer	0.000234	0.0131	CbGeAlD
Amlodipine—Immune system disorder—Capecitabine—esophageal cancer	0.000233	0.00361	CcSEcCtD
Amlodipine—Mediastinal disorder—Capecitabine—esophageal cancer	0.000233	0.00361	CcSEcCtD
Amlodipine—Chills—Capecitabine—esophageal cancer	0.000232	0.00359	CcSEcCtD
Amlodipine—CYP1A1—lung—esophageal cancer	0.000231	0.0129	CbGeAlD
Amlodipine—Arrhythmia—Capecitabine—esophageal cancer	0.000231	0.00357	CcSEcCtD
Amlodipine—Alopecia—Capecitabine—esophageal cancer	0.000228	0.00354	CcSEcCtD
Amlodipine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000227	0.00351	CcSEcCtD
Amlodipine—Mental disorder—Capecitabine—esophageal cancer	0.000226	0.00351	CcSEcCtD
Amlodipine—CYP3A5—lung—esophageal cancer	0.000226	0.0126	CbGeAlD
Amlodipine—Malnutrition—Capecitabine—esophageal cancer	0.000225	0.00348	CcSEcCtD
Amlodipine—Dysuria—Methotrexate—esophageal cancer	0.000225	0.00348	CcSEcCtD
Amlodipine—CYP2B6—lung—esophageal cancer	0.000225	0.0125	CbGeAlD
Amlodipine—Paraesthesia—Cisplatin—esophageal cancer	0.000224	0.00346	CcSEcCtD
Amlodipine—Dyspnoea—Cisplatin—esophageal cancer	0.000222	0.00344	CcSEcCtD
Amlodipine—Flatulence—Capecitabine—esophageal cancer	0.000222	0.00343	CcSEcCtD
Amlodipine—Erectile dysfunction—Methotrexate—esophageal cancer	0.000221	0.00343	CcSEcCtD
Amlodipine—Dysgeusia—Capecitabine—esophageal cancer	0.00022	0.00341	CcSEcCtD
Amlodipine—Back pain—Capecitabine—esophageal cancer	0.000217	0.00337	CcSEcCtD
Amlodipine—Decreased appetite—Cisplatin—esophageal cancer	0.000216	0.00335	CcSEcCtD
Amlodipine—Muscle spasms—Capecitabine—esophageal cancer	0.000216	0.00335	CcSEcCtD
Amlodipine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000215	0.00333	CcSEcCtD
Amlodipine—Pain—Cisplatin—esophageal cancer	0.000213	0.0033	CcSEcCtD
Amlodipine—Tremor—Capecitabine—esophageal cancer	0.000211	0.00326	CcSEcCtD
Amlodipine—Ill-defined disorder—Capecitabine—esophageal cancer	0.000209	0.00323	CcSEcCtD
Amlodipine—Conjunctivitis—Methotrexate—esophageal cancer	0.000208	0.00322	CcSEcCtD
Amlodipine—Feeling abnormal—Cisplatin—esophageal cancer	0.000205	0.00318	CcSEcCtD
Amlodipine—CYP3A4—digestive system—esophageal cancer	0.000203	0.0113	CbGeAlD
Amlodipine—Malaise—Capecitabine—esophageal cancer	0.000203	0.00314	CcSEcCtD
Amlodipine—Epistaxis—Methotrexate—esophageal cancer	0.000202	0.00313	CcSEcCtD
Amlodipine—Vertigo—Capecitabine—esophageal cancer	0.000202	0.00313	CcSEcCtD
Amlodipine—Syncope—Capecitabine—esophageal cancer	0.000202	0.00312	CcSEcCtD
Amlodipine—Leukopenia—Capecitabine—esophageal cancer	0.000201	0.00312	CcSEcCtD
Amlodipine—CYP2D6—digestive system—esophageal cancer	0.0002	0.0111	CbGeAlD
Amlodipine—Palpitations—Capecitabine—esophageal cancer	0.000199	0.00308	CcSEcCtD
Amlodipine—Loss of consciousness—Capecitabine—esophageal cancer	0.000198	0.00306	CcSEcCtD
Amlodipine—Cough—Capecitabine—esophageal cancer	0.000196	0.00304	CcSEcCtD
Amlodipine—Felodipine—ABCB1—esophageal cancer	0.000194	0.0708	CrCbGaD
Amlodipine—Haemoglobin—Methotrexate—esophageal cancer	0.000193	0.00299	CcSEcCtD
Amlodipine—Haemorrhage—Methotrexate—esophageal cancer	0.000192	0.00298	CcSEcCtD
Amlodipine—Hepatitis—Methotrexate—esophageal cancer	0.000192	0.00298	CcSEcCtD
Amlodipine—Arthralgia—Capecitabine—esophageal cancer	0.000191	0.00297	CcSEcCtD
Amlodipine—Chest pain—Capecitabine—esophageal cancer	0.000191	0.00297	CcSEcCtD
Amlodipine—Myalgia—Capecitabine—esophageal cancer	0.000191	0.00297	CcSEcCtD
Amlodipine—Anxiety—Capecitabine—esophageal cancer	0.000191	0.00295	CcSEcCtD
Amlodipine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00019	0.00294	CcSEcCtD
Amlodipine—Urinary tract disorder—Methotrexate—esophageal cancer	0.00019	0.00294	CcSEcCtD
Amlodipine—Discomfort—Capecitabine—esophageal cancer	0.000189	0.00293	CcSEcCtD
Amlodipine—ABCB1—epithelium—esophageal cancer	0.000189	0.0105	CbGeAlD
Amlodipine—Urethral disorder—Methotrexate—esophageal cancer	0.000188	0.00292	CcSEcCtD
Amlodipine—Nifedipine—ABCB1—esophageal cancer	0.000188	0.0685	CrCbGaD
Amlodipine—Dry mouth—Capecitabine—esophageal cancer	0.000187	0.0029	CcSEcCtD
Amlodipine—Visual impairment—Methotrexate—esophageal cancer	0.000185	0.00287	CcSEcCtD
Amlodipine—Nicardipine—ABCB1—esophageal cancer	0.000185	0.0674	CrCbGaD
Amlodipine—Oedema—Capecitabine—esophageal cancer	0.000183	0.00284	CcSEcCtD
Amlodipine—Hypersensitivity—Cisplatin—esophageal cancer	0.000183	0.00284	CcSEcCtD
Amlodipine—Erythema multiforme—Methotrexate—esophageal cancer	0.000182	0.00282	CcSEcCtD
Amlodipine—Shock—Capecitabine—esophageal cancer	0.000181	0.0028	CcSEcCtD
Amlodipine—Nervous system disorder—Capecitabine—esophageal cancer	0.00018	0.00279	CcSEcCtD
Amlodipine—Eye disorder—Methotrexate—esophageal cancer	0.00018	0.00278	CcSEcCtD
Amlodipine—Thrombocytopenia—Capecitabine—esophageal cancer	0.00018	0.00278	CcSEcCtD
Amlodipine—Tinnitus—Methotrexate—esophageal cancer	0.000179	0.00278	CcSEcCtD
Amlodipine—Tachycardia—Capecitabine—esophageal cancer	0.000179	0.00277	CcSEcCtD
Amlodipine—Asthenia—Cisplatin—esophageal cancer	0.000179	0.00277	CcSEcCtD
Amlodipine—Cardiac disorder—Methotrexate—esophageal cancer	0.000178	0.00276	CcSEcCtD
Amlodipine—Skin disorder—Capecitabine—esophageal cancer	0.000178	0.00276	CcSEcCtD
Amlodipine—Hyperhidrosis—Capecitabine—esophageal cancer	0.000177	0.00275	CcSEcCtD
Amlodipine—Anorexia—Capecitabine—esophageal cancer	0.000175	0.00271	CcSEcCtD
Amlodipine—Angiopathy—Methotrexate—esophageal cancer	0.000174	0.0027	CcSEcCtD
Amlodipine—Immune system disorder—Methotrexate—esophageal cancer	0.000174	0.00269	CcSEcCtD
Amlodipine—Mediastinal disorder—Methotrexate—esophageal cancer	0.000173	0.00268	CcSEcCtD
Amlodipine—Chills—Methotrexate—esophageal cancer	0.000173	0.00267	CcSEcCtD
Amlodipine—Diarrhoea—Cisplatin—esophageal cancer	0.00017	0.00264	CcSEcCtD
Amlodipine—Alopecia—Methotrexate—esophageal cancer	0.00017	0.00263	CcSEcCtD
Amlodipine—Mental disorder—Methotrexate—esophageal cancer	0.000168	0.00261	CcSEcCtD
Amlodipine—Malnutrition—Methotrexate—esophageal cancer	0.000167	0.00259	CcSEcCtD
Amlodipine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000167	0.00259	CcSEcCtD
Amlodipine—ABCB1—trachea—esophageal cancer	0.000167	0.00932	CbGeAlD
Amlodipine—Insomnia—Capecitabine—esophageal cancer	0.000166	0.00257	CcSEcCtD
Amlodipine—Paraesthesia—Capecitabine—esophageal cancer	0.000165	0.00255	CcSEcCtD
Amlodipine—Dysgeusia—Methotrexate—esophageal cancer	0.000164	0.00254	CcSEcCtD
Amlodipine—Dyspnoea—Capecitabine—esophageal cancer	0.000164	0.00253	CcSEcCtD
Amlodipine—Back pain—Methotrexate—esophageal cancer	0.000162	0.00251	CcSEcCtD
Amlodipine—Dyspepsia—Capecitabine—esophageal cancer	0.000162	0.0025	CcSEcCtD
Amlodipine—Decreased appetite—Capecitabine—esophageal cancer	0.00016	0.00247	CcSEcCtD
Amlodipine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000158	0.00245	CcSEcCtD
Amlodipine—Vomiting—Cisplatin—esophageal cancer	0.000158	0.00245	CcSEcCtD
Amlodipine—Fatigue—Capecitabine—esophageal cancer	0.000158	0.00245	CcSEcCtD
Amlodipine—CYP1A1—lymph node—esophageal cancer	0.000158	0.00882	CbGeAlD
Amlodipine—Rash—Cisplatin—esophageal cancer	0.000157	0.00243	CcSEcCtD
Amlodipine—Constipation—Capecitabine—esophageal cancer	0.000157	0.00243	CcSEcCtD
Amlodipine—Pain—Capecitabine—esophageal cancer	0.000157	0.00243	CcSEcCtD
Amlodipine—Dermatitis—Cisplatin—esophageal cancer	0.000157	0.00243	CcSEcCtD
Amlodipine—Ill-defined disorder—Methotrexate—esophageal cancer	0.000155	0.00241	CcSEcCtD
Amlodipine—Feeling abnormal—Capecitabine—esophageal cancer	0.000151	0.00234	CcSEcCtD
Amlodipine—Malaise—Methotrexate—esophageal cancer	0.000151	0.00234	CcSEcCtD
Amlodipine—Vertigo—Methotrexate—esophageal cancer	0.00015	0.00233	CcSEcCtD
Amlodipine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00015	0.00232	CcSEcCtD
Amlodipine—Leukopenia—Methotrexate—esophageal cancer	0.00015	0.00232	CcSEcCtD
Amlodipine—Nausea—Cisplatin—esophageal cancer	0.000148	0.00229	CcSEcCtD
Amlodipine—Cough—Methotrexate—esophageal cancer	0.000146	0.00226	CcSEcCtD
Amlodipine—Urticaria—Capecitabine—esophageal cancer	0.000146	0.00226	CcSEcCtD
Amlodipine—Abdominal pain—Capecitabine—esophageal cancer	0.000145	0.00225	CcSEcCtD
Amlodipine—ABCB1—digestive system—esophageal cancer	0.000144	0.00802	CbGeAlD
Amlodipine—Chest pain—Methotrexate—esophageal cancer	0.000142	0.00221	CcSEcCtD
Amlodipine—Arthralgia—Methotrexate—esophageal cancer	0.000142	0.00221	CcSEcCtD
Amlodipine—Myalgia—Methotrexate—esophageal cancer	0.000142	0.00221	CcSEcCtD
Amlodipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000142	0.00219	CcSEcCtD
Amlodipine—Discomfort—Methotrexate—esophageal cancer	0.000141	0.00218	CcSEcCtD
Amlodipine—Hypersensitivity—Capecitabine—esophageal cancer	0.000135	0.00209	CcSEcCtD
Amlodipine—Nervous system disorder—Methotrexate—esophageal cancer	0.000134	0.00208	CcSEcCtD
Amlodipine—Thrombocytopenia—Methotrexate—esophageal cancer	0.000134	0.00207	CcSEcCtD
Amlodipine—Skin disorder—Methotrexate—esophageal cancer	0.000133	0.00206	CcSEcCtD
Amlodipine—Hyperhidrosis—Methotrexate—esophageal cancer	0.000132	0.00205	CcSEcCtD
Amlodipine—Asthenia—Capecitabine—esophageal cancer	0.000132	0.00204	CcSEcCtD
Amlodipine—Anorexia—Methotrexate—esophageal cancer	0.00013	0.00202	CcSEcCtD
Amlodipine—Pruritus—Capecitabine—esophageal cancer	0.00013	0.00201	CcSEcCtD
Amlodipine—Diarrhoea—Capecitabine—esophageal cancer	0.000126	0.00194	CcSEcCtD
Amlodipine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000124	0.00193	CcSEcCtD
Amlodipine—Insomnia—Methotrexate—esophageal cancer	0.000124	0.00191	CcSEcCtD
Amlodipine—Paraesthesia—Methotrexate—esophageal cancer	0.000123	0.0019	CcSEcCtD
Amlodipine—Dyspnoea—Methotrexate—esophageal cancer	0.000122	0.00189	CcSEcCtD
Amlodipine—Somnolence—Methotrexate—esophageal cancer	0.000121	0.00188	CcSEcCtD
Amlodipine—Dizziness—Capecitabine—esophageal cancer	0.000121	0.00188	CcSEcCtD
Amlodipine—Dyspepsia—Methotrexate—esophageal cancer	0.00012	0.00186	CcSEcCtD
Amlodipine—ABCB1—lung—esophageal cancer	0.00012	0.0067	CbGeAlD
Amlodipine—Decreased appetite—Methotrexate—esophageal cancer	0.000119	0.00184	CcSEcCtD
Amlodipine—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000118	0.00183	CcSEcCtD
Amlodipine—Fatigue—Methotrexate—esophageal cancer	0.000118	0.00182	CcSEcCtD
Amlodipine—Pain—Methotrexate—esophageal cancer	0.000117	0.00181	CcSEcCtD
Amlodipine—Vomiting—Capecitabine—esophageal cancer	0.000117	0.00181	CcSEcCtD
Amlodipine—Rash—Capecitabine—esophageal cancer	0.000116	0.00179	CcSEcCtD
Amlodipine—Dermatitis—Capecitabine—esophageal cancer	0.000116	0.00179	CcSEcCtD
Amlodipine—Headache—Capecitabine—esophageal cancer	0.000115	0.00178	CcSEcCtD
Amlodipine—Feeling abnormal—Methotrexate—esophageal cancer	0.000113	0.00174	CcSEcCtD
Amlodipine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000112	0.00173	CcSEcCtD
Amlodipine—Nausea—Capecitabine—esophageal cancer	0.000109	0.00169	CcSEcCtD
Amlodipine—Urticaria—Methotrexate—esophageal cancer	0.000109	0.00168	CcSEcCtD
Amlodipine—Abdominal pain—Methotrexate—esophageal cancer	0.000108	0.00167	CcSEcCtD
Amlodipine—Hypersensitivity—Methotrexate—esophageal cancer	0.000101	0.00156	CcSEcCtD
Amlodipine—Asthenia—Methotrexate—esophageal cancer	9.8e-05	0.00152	CcSEcCtD
Amlodipine—Pruritus—Methotrexate—esophageal cancer	9.66e-05	0.0015	CcSEcCtD
Amlodipine—Diarrhoea—Methotrexate—esophageal cancer	9.35e-05	0.00145	CcSEcCtD
Amlodipine—Dizziness—Methotrexate—esophageal cancer	9.03e-05	0.0014	CcSEcCtD
Amlodipine—Vomiting—Methotrexate—esophageal cancer	8.68e-05	0.00135	CcSEcCtD
Amlodipine—Rash—Methotrexate—esophageal cancer	8.61e-05	0.00133	CcSEcCtD
Amlodipine—Dermatitis—Methotrexate—esophageal cancer	8.6e-05	0.00133	CcSEcCtD
Amlodipine—Headache—Methotrexate—esophageal cancer	8.56e-05	0.00133	CcSEcCtD
Amlodipine—ABCB1—lymph node—esophageal cancer	8.21e-05	0.00458	CbGeAlD
Amlodipine—Nausea—Methotrexate—esophageal cancer	8.11e-05	0.00126	CcSEcCtD
Amlodipine—CYP3A5—Metabolism—ALDH2—esophageal cancer	1.1e-05	8.49e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—CYP26A1—esophageal cancer	1.1e-05	8.45e-05	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—CYP19A1—esophageal cancer	1.09e-05	8.37e-05	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	1.09e-05	8.34e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—GAPDH—esophageal cancer	1.08e-05	8.32e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—PLCE1—esophageal cancer	1.08e-05	8.27e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—ADH7—esophageal cancer	1.08e-05	8.27e-05	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—GSTT1—esophageal cancer	1.08e-05	8.26e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—CRABP1—esophageal cancer	1.07e-05	8.25e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—ALOX15—esophageal cancer	1.07e-05	8.23e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—TYMP—esophageal cancer	1.07e-05	8.19e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.06e-05	8.18e-05	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—CYP2A6—esophageal cancer	1.06e-05	8.16e-05	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—CYP1B1—esophageal cancer	1.06e-05	8.16e-05	CbGpPWpGaD
Amlodipine—CACNA1D—Metabolism—NOS3—esophageal cancer	1.06e-05	8.15e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—TYMP—esophageal cancer	1.06e-05	8.11e-05	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—GSTT1—esophageal cancer	1.05e-05	8.07e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—ALDH2—esophageal cancer	1.04e-05	8.02e-05	CbGpPWpGaD
Amlodipine—CACNA1C—Metabolism—CREBBP—esophageal cancer	1.04e-05	8e-05	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—CYP2A6—esophageal cancer	1.04e-05	7.98e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—CYP26A1—esophageal cancer	1.04e-05	7.96e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—CYP26A1—esophageal cancer	1.03e-05	7.89e-05	CbGpPWpGaD
Amlodipine—CACNB2—Metabolism—PTGS2—esophageal cancer	1.02e-05	7.87e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—TPI1—esophageal cancer	1.02e-05	7.86e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—GSTO1—esophageal cancer	1.02e-05	7.86e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—GNG7—esophageal cancer	1.02e-05	7.84e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—ALOX15—esophageal cancer	1.01e-05	7.76e-05	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—PTGS1—esophageal cancer	1.01e-05	7.74e-05	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—ENO1—esophageal cancer	1.01e-05	7.74e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—ALOX15—esophageal cancer	1e-05	7.69e-05	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—CYP19A1—esophageal cancer	9.98e-06	7.67e-05	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—HMOX1—esophageal cancer	9.94e-06	7.63e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—GSTT1—esophageal cancer	9.93e-06	7.63e-05	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—PSME2—esophageal cancer	9.93e-06	7.63e-05	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—PSME1—esophageal cancer	9.93e-06	7.63e-05	CbGpPWpGaD
Amlodipine—CA1—Metabolism—EP300—esophageal cancer	9.86e-06	7.57e-05	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—ENO1—esophageal cancer	9.85e-06	7.56e-05	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—PTGS1—esophageal cancer	9.85e-06	7.56e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—CYP2A6—esophageal cancer	9.82e-06	7.54e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—ALDOB—esophageal cancer	9.81e-06	7.53e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—CA1—esophageal cancer	9.78e-06	7.51e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—SLC10A2—esophageal cancer	9.78e-06	7.51e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	9.78e-06	7.51e-05	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—PSME2—esophageal cancer	9.7e-06	7.45e-05	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—PSME1—esophageal cancer	9.7e-06	7.45e-05	CbGpPWpGaD
Amlodipine—CACNA1D—Metabolism—PTGS2—esophageal cancer	9.7e-06	7.45e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—GSTO1—esophageal cancer	9.64e-06	7.4e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—TPI1—esophageal cancer	9.64e-06	7.4e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—ALDH2—esophageal cancer	9.57e-06	7.35e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—GSTO1—esophageal cancer	9.56e-06	7.34e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—TPI1—esophageal cancer	9.56e-06	7.34e-05	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—ABCB1—esophageal cancer	9.54e-06	7.33e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—ADH1B—esophageal cancer	9.45e-06	7.26e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—GAPDH—esophageal cancer	9.44e-06	7.25e-05	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	9.42e-06	7.24e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—CRABP1—esophageal cancer	9.35e-06	7.18e-05	CbGpPWpGaD
Amlodipine—CACNA1C—Metabolism—NOS3—esophageal cancer	9.32e-06	7.16e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—PTGS1—esophageal cancer	9.3e-06	7.15e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—ENO1—esophageal cancer	9.3e-06	7.15e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—ALDOB—esophageal cancer	9.24e-06	7.1e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—PSME2—esophageal cancer	9.17e-06	7.04e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—PSME1—esophageal cancer	9.17e-06	7.04e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—ALDOB—esophageal cancer	9.16e-06	7.04e-05	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	9.11e-06	7e-05	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—HMOX1—esophageal cancer	9.11e-06	7e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—GSTT1—esophageal cancer	9.1e-06	6.99e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—TYMP—esophageal cancer	9.03e-06	6.93e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—CYP2A6—esophageal cancer	9e-06	6.91e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	8.96e-06	6.88e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—CA2—esophageal cancer	8.94e-06	6.87e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—GNG7—esophageal cancer	8.9e-06	6.83e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—GAPDH—esophageal cancer	8.9e-06	6.83e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—GAPDH—esophageal cancer	8.82e-06	6.77e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—CRABP1—esophageal cancer	8.82e-06	6.77e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—CYP26A1—esophageal cancer	8.78e-06	6.75e-05	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—ABCB1—esophageal cancer	8.74e-06	6.72e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—CRABP1—esophageal cancer	8.74e-06	6.71e-05	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—CYP1B1—esophageal cancer	8.57e-06	6.58e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—ALOX15—esophageal cancer	8.56e-06	6.57e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—ENO1—esophageal cancer	8.53e-06	6.55e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—PTGS1—esophageal cancer	8.53e-06	6.55e-05	CbGpPWpGaD
Amlodipine—CACNA1C—Metabolism—PTGS2—esophageal cancer	8.53e-06	6.55e-05	CbGpPWpGaD
Amlodipine—CACNB2—Metabolism—EP300—esophageal cancer	8.52e-06	6.55e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—PSME2—esophageal cancer	8.41e-06	6.46e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—PSME1—esophageal cancer	8.41e-06	6.46e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—GNG7—esophageal cancer	8.39e-06	6.44e-05	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—CYP1B1—esophageal cancer	8.37e-06	6.43e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—ALDH2—esophageal cancer	8.34e-06	6.4e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—ADH7—esophageal cancer	8.32e-06	6.39e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—PLCE1—esophageal cancer	8.32e-06	6.39e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—GNG7—esophageal cancer	8.31e-06	6.38e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—TPI1—esophageal cancer	8.17e-06	6.27e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—GSTO1—esophageal cancer	8.17e-06	6.27e-05	CbGpPWpGaD
Amlodipine—CACNA1D—Metabolism—EP300—esophageal cancer	8.07e-06	6.2e-05	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—CYP19A1—esophageal cancer	8.06e-06	6.19e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	8.01e-06	6.15e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—GSTT1—esophageal cancer	7.93e-06	6.09e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—CYP1B1—esophageal cancer	7.91e-06	6.08e-05	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—CYP19A1—esophageal cancer	7.87e-06	6.05e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—ALDH2—esophageal cancer	7.86e-06	6.03e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—CYP2A6—esophageal cancer	7.84e-06	6.02e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—ALDOB—esophageal cancer	7.83e-06	6.01e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—ALDH2—esophageal cancer	7.79e-06	5.98e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—GAPDH—esophageal cancer	7.54e-06	5.79e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—GSTT1—esophageal cancer	7.47e-06	5.74e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—CRABP1—esophageal cancer	7.47e-06	5.74e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—CYP19A1—esophageal cancer	7.44e-06	5.71e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—PTGS1—esophageal cancer	7.43e-06	5.71e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—ENO1—esophageal cancer	7.43e-06	5.71e-05	CbGpPWpGaD
Amlodipine—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	7.43e-06	5.7e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—GSTT1—esophageal cancer	7.41e-06	5.69e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—CYP2A6—esophageal cancer	7.39e-06	5.67e-05	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—HMOX1—esophageal cancer	7.35e-06	5.65e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.34e-06	5.64e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—CYP2A6—esophageal cancer	7.32e-06	5.62e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—PSME1—esophageal cancer	7.32e-06	5.62e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—PSME2—esophageal cancer	7.32e-06	5.62e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	7.3e-06	5.6e-05	CbGpPWpGaD
Amlodipine—CA1—Metabolism—PIK3CA—esophageal cancer	7.29e-06	5.6e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—ADH1B—esophageal cancer	7.29e-06	5.6e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—CYP1B1—esophageal cancer	7.25e-06	5.57e-05	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—HMOX1—esophageal cancer	7.18e-06	5.52e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—GNG7—esophageal cancer	7.1e-06	5.46e-05	CbGpPWpGaD
Amlodipine—CACNA1C—Metabolism—EP300—esophageal cancer	7.09e-06	5.45e-05	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—ABCB1—esophageal cancer	7.06e-06	5.42e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—PTGS1—esophageal cancer	7e-06	5.38e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—ENO1—esophageal cancer	7e-06	5.38e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—TYMP—esophageal cancer	6.97e-06	5.35e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—PTGS1—esophageal cancer	6.94e-06	5.33e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—ENO1—esophageal cancer	6.94e-06	5.33e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—PSME1—esophageal cancer	6.9e-06	5.3e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—PSME2—esophageal cancer	6.9e-06	5.3e-05	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—ABCB1—esophageal cancer	6.9e-06	5.3e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—PSME1—esophageal cancer	6.84e-06	5.25e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—PSME2—esophageal cancer	6.84e-06	5.25e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—CYP19A1—esophageal cancer	6.82e-06	5.24e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—HMOX1—esophageal cancer	6.79e-06	5.21e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	6.78e-06	5.21e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6.66e-06	5.11e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—ALDH2—esophageal cancer	6.66e-06	5.11e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—ALOX15—esophageal cancer	6.61e-06	5.07e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—ABCB1—esophageal cancer	6.52e-06	5e-05	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—CREBBP—esophageal cancer	6.38e-06	4.9e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—GSTT1—esophageal cancer	6.33e-06	4.86e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—CYP1B1—esophageal cancer	6.32e-06	4.85e-05	CbGpPWpGaD
Amlodipine—CACNB2—Metabolism—PIK3CA—esophageal cancer	6.3e-06	4.84e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—TPI1—esophageal cancer	6.3e-06	4.84e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—GSTO1—esophageal cancer	6.3e-06	4.84e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—CYP2A6—esophageal cancer	6.26e-06	4.81e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	6.23e-06	4.79e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—HMOX1—esophageal cancer	6.22e-06	4.78e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6.1e-06	4.69e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—ALDOB—esophageal cancer	6.04e-06	4.64e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	5.97e-06	4.59e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—ABCB1—esophageal cancer	5.97e-06	4.59e-05	CbGpPWpGaD
Amlodipine—CACNA1D—Metabolism—PIK3CA—esophageal cancer	5.97e-06	4.59e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—CYP1B1—esophageal cancer	5.95e-06	4.57e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—CYP19A1—esophageal cancer	5.94e-06	4.56e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—ENO1—esophageal cancer	5.93e-06	4.56e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—PTGS1—esophageal cancer	5.93e-06	4.56e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—CYP1B1—esophageal cancer	5.9e-06	4.53e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—PSME2—esophageal cancer	5.85e-06	4.49e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—PSME1—esophageal cancer	5.85e-06	4.49e-05	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—CREBBP—esophageal cancer	5.84e-06	4.49e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—GAPDH—esophageal cancer	5.82e-06	4.47e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—CRABP1—esophageal cancer	5.76e-06	4.43e-05	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—NOS3—esophageal cancer	5.71e-06	4.38e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—CYP19A1—esophageal cancer	5.6e-06	4.3e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—CYP19A1—esophageal cancer	5.55e-06	4.26e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—GNG7—esophageal cancer	5.48e-06	4.21e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—HMOX1—esophageal cancer	5.42e-06	4.16e-05	CbGpPWpGaD
Amlodipine—CACNA1C—Metabolism—PIK3CA—esophageal cancer	5.25e-06	4.03e-05	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—NOS3—esophageal cancer	5.23e-06	4.02e-05	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—PTGS2—esophageal cancer	5.22e-06	4.01e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—ALDH2—esophageal cancer	5.14e-06	3.95e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—HMOX1—esophageal cancer	5.11e-06	3.92e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	5.11e-06	3.92e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—HMOX1—esophageal cancer	5.06e-06	3.89e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—CYP1B1—esophageal cancer	5.04e-06	3.87e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	4.97e-06	3.82e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.93e-06	3.78e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—ABCB1—esophageal cancer	4.9e-06	3.77e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—GSTT1—esophageal cancer	4.89e-06	3.75e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—ABCB1—esophageal cancer	4.86e-06	3.73e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	4.83e-06	3.71e-05	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—PTGS2—esophageal cancer	4.79e-06	3.68e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—CYP19A1—esophageal cancer	4.74e-06	3.64e-05	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—CREBBP—esophageal cancer	4.72e-06	3.62e-05	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—CREBBP—esophageal cancer	4.61e-06	3.54e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—PTGS1—esophageal cancer	4.58e-06	3.52e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—ENO1—esophageal cancer	4.58e-06	3.52e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.52e-06	3.47e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—PSME1—esophageal cancer	4.51e-06	3.47e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—PSME2—esophageal cancer	4.51e-06	3.47e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—CREBBP—esophageal cancer	4.35e-06	3.34e-05	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—EP300—esophageal cancer	4.34e-06	3.34e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—HMOX1—esophageal cancer	4.33e-06	3.32e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	4.25e-06	3.26e-05	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—NOS3—esophageal cancer	4.22e-06	3.24e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—ABCB1—esophageal cancer	4.15e-06	3.19e-05	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—NOS3—esophageal cancer	4.13e-06	3.17e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—CREBBP—esophageal cancer	3.99e-06	3.07e-05	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—EP300—esophageal cancer	3.98e-06	3.06e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—NOS3—esophageal cancer	3.9e-06	2.99e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	3.89e-06	2.99e-05	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—PTGS2—esophageal cancer	3.86e-06	2.97e-05	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—PTGS2—esophageal cancer	3.77e-06	2.9e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.68e-06	2.82e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	3.66e-06	2.81e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—NOS3—esophageal cancer	3.57e-06	2.75e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—PTGS2—esophageal cancer	3.57e-06	2.74e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—CREBBP—esophageal cancer	3.48e-06	2.67e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.34e-06	2.57e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—CREBBP—esophageal cancer	3.28e-06	2.52e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—PTGS2—esophageal cancer	3.27e-06	2.51e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—CREBBP—esophageal cancer	3.25e-06	2.5e-05	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—PIK3CA—esophageal cancer	3.21e-06	2.47e-05	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—EP300—esophageal cancer	3.21e-06	2.47e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.21e-06	2.46e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.14e-06	2.41e-05	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—EP300—esophageal cancer	3.14e-06	2.41e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—NOS3—esophageal cancer	3.11e-06	2.39e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—EP300—esophageal cancer	2.97e-06	2.28e-05	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—PIK3CA—esophageal cancer	2.94e-06	2.26e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—NOS3—esophageal cancer	2.93e-06	2.25e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—NOS3—esophageal cancer	2.91e-06	2.23e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—PTGS2—esophageal cancer	2.85e-06	2.19e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—CREBBP—esophageal cancer	2.78e-06	2.13e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—EP300—esophageal cancer	2.72e-06	2.09e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—PTGS2—esophageal cancer	2.68e-06	2.06e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—PTGS2—esophageal cancer	2.66e-06	2.04e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—NOS3—esophageal cancer	2.49e-06	1.91e-05	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—PIK3CA—esophageal cancer	2.38e-06	1.82e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—EP300—esophageal cancer	2.37e-06	1.82e-05	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—PIK3CA—esophageal cancer	2.32e-06	1.78e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—PTGS2—esophageal cancer	2.27e-06	1.75e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—EP300—esophageal cancer	2.23e-06	1.71e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—EP300—esophageal cancer	2.21e-06	1.7e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—PIK3CA—esophageal cancer	2.19e-06	1.68e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.14e-06	1.65e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—PIK3CA—esophageal cancer	2.01e-06	1.54e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—NOS3—esophageal cancer	1.92e-06	1.47e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—EP300—esophageal cancer	1.89e-06	1.45e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.75e-06	1.35e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—PIK3CA—esophageal cancer	1.75e-06	1.35e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—PIK3CA—esophageal cancer	1.65e-06	1.27e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—PIK3CA—esophageal cancer	1.64e-06	1.26e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—EP300—esophageal cancer	1.46e-06	1.12e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—PIK3CA—esophageal cancer	1.4e-06	1.07e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.08e-06	8.29e-06	CbGpPWpGaD
